Pharmacognosy intro
Cat's Claw contains two pharmacologically distinct alkaloid classes: Pentacyclic Oxindole Alkaloids (POA, mitraphylline, isomitraphylline, pteropodine, isopteropodine, speciophylline, uncarine F) which are IMMUNOSTIMULATORY and therapeutically desired, and Tetracyclic Oxindole Alkaloids (TOA, rhynchophylline, isorhynchophylline) which have DIFFERENT and potentially ANTAGONISTIC effects, counteracting POA immunostimulatory activity. Additional compounds include quinovic acid glycosides (anti-inflammatory, antiviral), proanthocyanidins (antioxidant), catechins, triterpenes (ursolic acid, oleanolic acid), and beta-sitosterol. THE POA/TOA DISTINCTION IS CRITICAL: plant chemotype, harvesting season, geographic location, and time of day affect the ratio. TOA-dominant preparations may be therapeutically inert or counterproductive. The PRIMARY mechanism involves POA immunomodulation, enhancing B and T lymphocyte proliferation, increasing phagocytic activity, and modulating cytokine production. This is IMMUNOMODULATORY, not simply immunostimulatory, POA can upregulate suppressed immunity AND calm overactive immunity. Both POA and quinovic acid glycosides inhibit NF-kB activation, reducing TNF-alpha, IL-1beta, and IL-6. POA (specifically isopteropodine) enhances DNA repair mechanisms, potentially protecting against mutagenesis. TOA ANTAGONISM is the key quality concern: a preparation with high TOA/POA ratio will have reduced immune benefit.